Unknown

Dataset Information

0

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of ?-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity.

ABSTRACT: Introduction:In order to develop novel anticancer HDAC/tubulin dual inhibitors, a novel series of ?-phthalimido-substituted chalcones-based hybrids was synthesized and characterized by IR, 1H NMR, 13C NMR, mass spectroscopy and X-ray analysis. Methods:All the synthesized compounds were evaluated for their in vitro anticancer activity against MCF-7 and HepG2 human cancer cell lines using MTT assay. To explore the mechanism of action of the synthesized compounds, in vitro ?-tubulin polymerization and HDAC 1 and 2 inhibitory activity were measured for the most potent anticancer hybrids. Further, cell cycle analysis was also evaluated. Results:The trimethoxy derivative 7j showed the most potent anticancer activity, possessed the most potent ?-tubulin polymerase and HDAC 1 and 2 inhibitory activity and efficiently induced cell cycle arrest at both G2/M and preG1phases in the MCF-7 cell line.

SUBMITTER: Mourad AAE 

PROVIDER: S-EPMC7425103 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity.

Mourad Ahmed A E AAE   Mourad Mai A E MAE   Jones Peter G PG  

Drug design, development and therapy 20200803

<h4>Introduction</h4>In order to develop novel anticancer HDAC/tubulin dual inhibitors, a novel series of α-phthalimido-substituted chalcones-based hybrids was synthesized and characterized by IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, mass spectroscopy and X-ray analysis.<h4>Methods</h4>All the synthesized compounds were evaluated for their in vitro anticancer activity against MCF-7 and HepG2 human cancer cell lines using MTT assay. To explore the mechanism of action of the synthesized compound  ...[more]

Similar Datasets

Unknown Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors.
| S-EPMC8954831 | biostudies-literature
Unknown Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV<sup>600E</sup>.
| S-EPMC10504751 | biostudies-literature
Unknown Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2-<i>a</i>]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity.
| S-EPMC10177692 | biostudies-literature
Unknown Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents.
| S-EPMC6177136 | biostudies-literature
Unknown Design, Synthesis, and Molecular Docking of Paracyclophanyl-Thiazole Hybrids as Novel CDK1 Inhibitors and Apoptosis Inducing Anti-Melanoma Agents.
| S-EPMC7729638 | biostudies-literature
Unknown Design, One Pot Synthesis and Molecular Docking Studies of Substituted-1H-Pyrido[2,1-b] Quinazolines as Apoptosis-Inducing Anticancer Agents.
| S-EPMC7332124 | biostudies-literature
Unknown Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
| S-EPMC6032053 | biostudies-literature
Unknown Coumarin-amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition.
| S-EPMC11302324 | biostudies-literature
Unknown Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation.
| S-EPMC7758046 | biostudies-literature
Unknown Tubulin-interactive natural products as anticancer agents.
| S-EPMC2765517 | biostudies-other